About Oceana

Latest News

Oceana Therapeutics Announces Definitive Agreement to be Acquired by Salix...

Accolades


EXECUTIVE MANAGEMENT

Steven M. Bosacki
Senior Vice President, General Counsel

Before Oceana, Steve Bosacki  was Vice President and General Counsel for Esprit Pharma, Inc., a specialty pharmaceuticals company focusing on the sale and marketing of therapies for the genito-urinary market, including its flagship product Sanctura.   He was actively involved in the acquisition and divestiture of several products for Esprit, and in connection with the ultimate sale of the company to Allergan, Inc. in 2007   Prior to joining Esprit, Steve  served as Senior Vice President of Commercial Operations for Saturn Pharmaceuticals, the company that originally acquired the rights to Sanctura from Indevus Pharmaceuticals.   Previously, he was Vice President of Client and Support Services for Cardinal Health, which was, acquired Boron Lepore in 2004.  At the time of the acquisition, Mr. Bosacki was Vice President and General Manager of the Field Force Logistics division of Boron Lepore, which had planned and executed over 140,000 meetings and had annual revenues of over $80 million.  During his tenure there, from 1998 to 2004, Steve worked with numerous pharmaceutical clients such as Bristol Myers-Squibb, Pfizer, Roche, Sanofi and Shire.  He was also a member of the Operating Board, responsible for the integration of various business units in the Boron Lepore portfolio.  Prior to joining Boron Lepore, he was an attorney in private practice in transactional, banking and general corporate law.  

Mr. Bosacki is a member of the State Bar of New Jersey and was admitted to the Law Society of Upper Canada (Ontario).  He received a Bachelor of Commerce and an M.B.A from the University of Windsor and also has a J.D. and an LL.B having completed joint laws degrees from the University of Detroit and University of Windsor.  

«back

-